Systematic review protocol for assessing central auditory functions of Alzheimer\u27s disease and its preclinical stages by Jayakody, Dona M.P. et al.
Edith Cowan University 
Research Online 
ECU Publications Post 2013 
6-22-2020 
Systematic review protocol for assessing central auditory 
functions of Alzheimer's disease and its preclinical stages 
Dona M.P. Jayakody 
Hadeel Y. Tarawneh 
Holly K. Menegola 
Jessica M. Yiannos 
Peter L. Friedland 
See next page for additional authors 
Follow this and additional works at: https://ro.ecu.edu.au/ecuworkspost2013 
 Part of the Medicine and Health Sciences Commons 
10.1136/bmjopen-2019-033342 
Jayakody, D. M., Tarawneh, H. Y., Menegola, H. K., Yiannos, J. M., Friedland, P. L., Wilson, W. J., ... & Sohrabi, H. R. 
(2020). Systematic review protocol for assessing central auditory functions of Alzheimer’s disease and its 
preclinical stages. BMJ open, 10(6), e033342. https://doi.org/10.1136/bmjopen-2019-033342 
This Journal Article is posted at Research Online. 
https://ro.ecu.edu.au/ecuworkspost2013/8589 
Authors 
Dona M.P. Jayakody, Hadeel Y. Tarawneh, Holly K. Menegola, Jessica M. Yiannos, Peter L. Friedland, 
Wayne J. Wilson, Ralph N. Martins, and Hamid R. Sohrabi 
This journal article is available at Research Online: https://ro.ecu.edu.au/ecuworkspost2013/8589 
1Jayakody DMP, et al. BMJ Open 2020;10:e033342. doi:10.1136/bmjopen-2019-033342
Open access 
Systematic review protocol for assessing 
central auditory functions of 
Alzheimer’s disease and its 
preclinical stages
Dona M P Jayakody   ,1,2 Hadeel Y Tarawneh   ,1,2,3 Holly K Menegola,1,2 
Jessica M Yiannos,1,2 Peter L Friedland,1,4,5 Wayne J Wilson,6 Ralph N Martins,7,8 
Hamid R Sohrabi7,8,9
To cite: Jayakody DMP, 
Tarawneh HY, Menegola HK, 
et al.  Systematic review 
protocol for assessing 
central auditory functions of 
Alzheimer’s disease and its 
preclinical stages. BMJ Open 
2020;10:e033342. doi:10.1136/
bmjopen-2019-033342
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2019- 
033342).
Received 02 August 2019
Revised 06 May 2020
Accepted 12 May 2020
For numbered affiliations see 
end of article.
Correspondence to
Hadeel Y Tarawneh;  
 hadeel. tarawneh@ research. 
uwa. edu. au and  
Dr Dona M P Jayakody;  
 dona. jayakody@ earscience. 
org. au
Protocol
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
Strengths and limitations of this study
 ► The systematic review, this protocol outlines, will 
contribute to strengthen the understanding of the 
strengths and limitations of behavioural central 
auditory function assessments in individuals with 
Alzheimer’s disease (AD) and those at risk of devel-
oping AD.
 ► This systematic review protocol is described in 
accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta- Analyses Protocols 
guidelines.
 ► There are no language restrictions imposed for the 
full- text literature search for this systematic review.
 ► Exclusion of articles with abstracts not in English can 
potentially mean that important findings are missed.
 ► The manuscript only describes a protocol for a sys-
tematic review. A follow- up manuscript will explore 
the systematic review results and meta- analysis of 
the data.
AbStrACt
Introduction A number of studies have reported an 
association between peripheral hearing impairment, 
central auditory processing and Alzheimer’s disease 
(AD) and its preclinical stages. Both peripheral hearing 
impairment and central auditory processing disorders are 
observed many years prior to the clinical manifestation 
of AD symptoms, hence, providing a long window of 
opportunity to investigate potential interventions against 
neurodegenerative processes. This paper outlines the 
protocol for a systematic review of studies examining 
the central auditory processing functions in AD and its 
preclinical stages, investigated through behavioural 
(clinical assessments that require active participation) 
central auditory processing tests.
Methods and analysis We will use the keywords and 
Medical Subject Heading terms to search the following 
electronic databases: MEDLINE, PsychINFO, PubMed, 
Scopus, EMBASE and CINAHL Plus. Studies including 
assessments of central auditory function in adults 
diagnosed with dementia, AD and its preclinical stages that 
were published before 8 May 2019 will be reviewed. This 
review protocol will be reported according to the Preferred 
Reporting Items for Systematic Reviews and Meta- Analyses 
Protocols guidelines. Data analysis and search results will 
be reported in the full review. This manuscript has designed 
the protocols for a systematic review that will identify the 
behavioural clinical central auditory processing measures 
that are sensitive to the changes in auditory function in 
adults with AD and its preclinical stages. Such assessments 
may subsequently help to design studies to examine 
the potential impact of hearing and communication 
rehabilitation of individuals at risk of AD.
Ethics and dissemination Ethical approval is not 
required as this manuscript only reports the protocols 
for conducting a systematic review as primary data 
will only be reviewed and not be collected. The results 
of this systematic review will be disseminated through 
publication and in scientific conferences.
PrOSPErO registration number CRD42017078272.
IntrOduCtIOn
Globally, about 44 million people were living 
with Alzheimer’s disease (AD) or related 
dementia in 2017 and this number is projected 
to reach 76 million by 2050.1 The preclinical 
and prodromal stages of AD include subjec-
tive cognitive decline (SCD), mild cognitive 
impairment (MCI) and dementia.2–4 Not 
all those with SCD or MCI may progress to 
AD, only a certain per cent of individuals will 
proceed to the next neurodegenerative stage.5 
The neuropathological changes associated 
with AD have been shown to start up to 20 
years prior to the clinically manifested symp-
toms.6 This long pre- clinical phase provides 
a rare opportunity for early detection and 
prevention of the disease, and it is now esti-
mated that up to 35% of AD diagnoses world-
wide could be delayed or prevented with early 
intervention and by making lifestyle changes 
whichthat reduce the identified modifiable 
risk factors for developing AD.7 8 Identifying 
these early markers of AD as well as the poten-
tial factors which will help prevent or delay 
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both age- related and pathological cognitive declines in 
AD becomes particularly important considering there is 
no cure or effective treatment currently insight.
According to Lancet International Commission on 
Dementia Prevention, Intervention, and Care report, 
mid- life hearing loss could account for 9% of the popu-
lation attributable fraction of modifiable risk factors asso-
ciated with increased risk of AD.7 The auditory system is 
comprised of two key components, the peripheral hearing 
system (outer, middle and inner ear and auditory nerve) 
and the central auditory pathway (cochlear nucleus to the 
auditory cortex), which are respectively involved in the 
detection and processing of incoming auditory signal.9 
The central auditory system is responsible for key commu-
nication skills such as feature extraction and detecting 
small gaps in speech, which is crucial in speech discrimi-
nation and integrating and separating binaural auditory 
information.10 11 A combination of these central auditory 
processing (CAP) skills facilitates the understanding of 
speech in background noise and spatial processing skills 
as well as language and information processing.10 11
Results from longitudinal studies suggest that CAP 
skills, in the absence of a severe peripheral hearing loss, 
are associated with high incidences of cognitive decline 
and AD dementia.12–14 These studies have demonstrated 
that those with severe CAP disorders (<50% scores on 
Dichotic Sentence Identification task) were at a greater 
risk for incident dementia with hazard ratios of 9.9 (95% 
CI 3.6 to 26.7).13
Further, a number of studies have reported impaired 
CAP skills in individuals with MCI.13 15 16 The exact mech-
anism underlying the impaired CAP skills and cognitive 
decline is yet to be elucidated, two theories have been 
proposed to explain this association. The first theory 
suggests that it could result from independent decline 
in both CAP skills and cognition, exhausting cognitive 
reserve and exacerbating the deficits experienced in both 
CAP skills and cognitive abilities, manifesting as language, 
learning and communication difficulties.11 The second 
theory suggests that cortical degeneration of common 
neuronal structures, resulting from neurodegenerative 
disorders such as dementia and AD, could lead to deficits 
in speech, hearing and cognitive processes.12 17
Numerous studies to date have concluded that there 
is a strong link between poor central auditory functions 
and the preclinical stages of AD. This link could provide 
a unique opportunity to easily identify people at high 
risk of developing, or who are in the preclinical phases 
of AD, years before a formal diagnosis can be made. 1819 
Based on existing meta- analyses data, Norton et al8 calcu-
lated the population attributable risk of AD worldwide, 
UK, USA and Europe for seven modifiable risk factors 
that have been associated with AD: diabetes, midlife 
hypertension, midlife obesity, physical inactivity, depres-
sion, smoking and low educational attainment. Based 
on the assumption of a causal relationship between AD 
and risk factors and timely intervention, the effect of risk 
factor reductions on AD projections from 2010 to 2050 
for each of the seven risk factors was calculated. Results 
suggested that if the risk factor was reduced by 10% or 
20% per decade for each of the seven risk factors, the 
projected cases of worldwide AD could be reduced by 8.3 
to 16.2 million by 2050.8 It is important that we evaluate 
the validity and reliability of the central auditory function 
tests used in preclinical AD (SCD, MCI and dementia) 
before proceeding to develop tests or intervention strate-
gies for people identified to have poor CAP skills.
This paper outlines the protocol that will be used to 
systematically review the behavioural central auditory 
function assessments of 40–85- year- old people diag-
nosed with AD and its preclinical stages and compares 
the results with the 40–85- year- old healthy adults with 
no cognitive impairment or memory complaints. The 
systematic review will also examine the (1) challenges 
pertaining to selection and administration of behavioural 
CAP assessments to those with impaired cognitive and/or 
daily living functions, (2) modifications to the standard 
central hearing assessment procedures to accommodate 
impaired cognitive and/or daily living functions and 
(3) the factors that influence the interpretation of test 
results. Two research questions will be investigated: (1) 
What are the most commonly utilised behavioural CAP 
tests for older adults diagnosed with AD or in preclinical 
stages and (2) What are the limitations of these measures 
and how can they be improved?
MEthOdS And AnAlySIS
This protocol will be reported in accordance with the 
Preferred Reporting Items for Systematic Reviews and 
Meta- Analyses Protocols 2015 checklist.20
Patient and public involvement
This was a protocol paper for reviewing previously 
published papers. Therefore, no patient or patient- 
related data were required, assessed or involved in any 
part of this protocol preparation.
Criteria
All papers related to behavioural central auditory func-
tions and AD dementia, MCI and SCD that were published 
and available on searched databases before 8 May 2019 
will be considered. The inclusion and exclusion criteria 
are described below.
Population
Adults aged between 40 and 85 years with typical ‘amnestic 
MCI, dementia due to AD, non- amnestic MCI and SCD’ 
will be included. Other cognitive impairments not related 
to AD, including logopenic progressive aphasia, primary 
progressive aphasia, posterior cortical atrophy and frontal 
variant AD, will be excluded. Participants with visual 
impairment also will be excluded.
Intervention
Behavioural central auditory function tests that measure 
(1) monaural low redundancy speech tests (low- pass 
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Table 1 Keywords and Medical Subject Headings (MeSH) terms (explode) applied per domain in search databases
Domain Keywords MeSH terms
Central 
auditory 
tests
Central hearing OR central hearing loss OR central hearing impairment OR central 
hearing decline OR central presbycusis OR auditory processing OR central auditory 
processing OR central auditory deficit* OR auditory processing disorder* OR speech- 
in- noise OR gaps- in- noise OR dichotic processing OR dichotic digit test* OR dichotic 
word listening test* OR dichotic sentence test* OR dichotic sentence identification 
test* OR DSI* OR dichotic CV* OR dichotic rhymes OR staggered spondaic word test* 
OR synthetic sentence identification OR competing sentences OR SSI* OR temporal 
processing OR temporal resolution OR temporal pattern test* OR frequency pattern 
test* OR pitch pattern test* OR duration pattern test* OR temporal discrimination OR 
frequency discrimination OR pitch discrimination OR masking level difference OR 
MLD* OR gap detection OR gap discrimination OR gaps in noise OR GIN* OR random 
gap detection test* OR RGDT* OR adaptive test of temporal resolution OR ATTR* 
OR temporal integration OR temporal masking OR binaural interaction OR binaural 
separation OR binaural integration OR lateralization OR lateralization OR localization 
OR localization OR inter- aural time differences OR inter- aural time difference OR 
ITD*OR order identification OR temporal masking OR inter- aural intensity difference 
OR inter- aural intensity difference OR IID* OR spatial processing OR rapidly alternating 
speech perception OR RASP* OR listening in spatialized noise OR LisN* OR listening 
in spatialized noise- continuous discourse test OR LISN- CD* OR listening in spatialized 
noise- sentences test OR LISN- S*
Hearing Loss OR 
Central Auditory 
diseases OR Auditory 
perception
Alzheimer’s 
disease
Alzheimer* disease OR Alzheimer’s* OR Dementia OR AD OR cognitive impairment OR 
cognitive decline OR cognitive processing OR cognitive ability dementia OR Alzheimer* 
type dementia OR mild cognitive impairment OR MCI OR amnestic MCI OR amnestic 
mild cognitive impairment OR minimal cognitive impairment OR moderate cognitive 
impairment OR severe cognitive impairment OR memory complainers OR SMC OR 
subjective cognitive decline OR SCD, or cognitive impairment no dementia OR CIND
Dementia OR 
Cognitive Dysfunction 
OR Cognitive defect
filtered speech tests, speech- in- noise tests, speech- in- 
message competition tests, time- compressed speech 
tests), (2) temporal processing (temporal ordering or 
sequencing, temporal resolution or discrimination, 
temporal integration or summation, temporal masking), 
(3) binaural interaction (masking- level difference, inter-
aural timing and lateralisation/localisation, binaural 
fusion, rapidly alternating speech perception) and (4) 
dichotic listening (dichotic digits, dichotic sentences, 
staggered spondaic word test, dichotic consonant–vowels, 
dichotic rhymes) will be included. Auditory electrophysi-
ological assessments will be excluded from the review.
Comparator
The control group will consist of healthy adults aged from 
40 to 85 years. Those with cognitive complaints, neuro-
cognitive impairment, impaired daily living functions and 
visual impairment will be excluded.
Outcomes
Only quantitative measurements will be included. Both 
cross- sectional and longitudinal studies that documented 
the changes of the central auditory functions of adults 
diagnosed AD and its preclinical stages will be included.
Study type
Randomised controlled trials, feasibility studies, pilot 
studies and clinical trials will be considered.
No language restrictions will be imposed during the liter-
ature search, however, the abstract should be available in 
English. All studies should be original research published 
in a peer- reviewed journal.
Information sources
The following databases will be selected: MEDLINE, 
PsychINFO, PubMed, Scopus, EMBASE and CINAHL 
Plus electronic databases, which are the most likely to 
index reports of studies in audiology, speech and hearing, 
psychology, cognition, neuroscience, neuropsychology 
and cognitive sciences, psychiatry and mental health. A 
hand- search of references of the included articles will also 
be performed as well. Grey literature will be sought using 
Google Scholar, Open Grey,  ClinicalTrials. gov and Inter-
national Clinical Trials Registry Platform. Unpublished 
studies from conference proceedings, scientific meetings 
or thesis were included in the search to mitigate publica-
tion bias.
Search strategy
To maximise the sensitivity of the search strategy, the 
following will be used: MeSH terms in exploded mode 
(MEDLINE, PsychINFO and EMBASE), text searches or 
keywords (PubMed, CINAHL Plus and Scopus), with trun-
cations, synonyms and different spellings. The searches 
will be conducted in the title, abstract and full- text fields. 
Each combination of identifiers between domains will be 
searched when occurring concurrently in the same report 
(refer to table 1).
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In order to account for all the behavioural central audi-
tory hearing assessments that were not covered by the 
keywords and MeSH terms, we will also include any test 
that measures monaural low redundancy speech/tones, 
dichotic listening tests consist of musical notes/chords, 
temporal processing and binaural interaction tasks.
A dual independent review will be applied to the search 
strategy as well as to the processes of identification and 
assessment of studies to reduce random errors and bias.21 
The search strategy will also be reviewed by an indepen-
dent librarian.22
data management
All results from database and hand searches will be 
exported into EndNote V.X7 software (Thomson Reuters 
2016) and then into the Covidence software program for 
systematic reviews ( www. covidence. org). All the selected 
articles will then be independently screened using the 
Covidence software program.
Study selection
After removing the duplicates, titles and abstracts will be 
analysed against the study eligibility criteria (HYT and 
HM). Papers without abstract or abstracts that lack infor-
mation will be kept for full- text analysis. The manuscripts 
kept for full- text analysis will be also screened by a third 
researcher (DMPJ). Discrepancies will be resolved by 
consensus. Reference lists and citations of the included 
papers and grey literature will be analysed to identify 
other potentially relevant papers (DMPJ).
data extraction
The information extracted from screened articles will 
include the following (1) authors of the paper, year of 
publication and journal, (2) geographical location of 
the study, (3) demographics of the participants, (4) aims 
of the study, (5) types of the tests used, (6) outcomes 
measured, (7) major findings (results/conclusions), (8) 
limitations or difficulties. If data are not clearly presented 
in the research article, the authors of the original article 
will be contacted via email for further clarifications. Data 
will be reported under four subgroups: normal cognitive 
functions (controls), AD, MCI and SCD.
Quality assessment
The included studies will be assessed (internal validity 
or reliability) to address the following risk of bias: (1) 
selection bias, (2) performance bias, (3) detection bias, 
(4) attrition bias, (5) analysis bias and (6) reporting bias 
will be observed. A quality assessment tool developed by 
Thomas et al. 23 will be used to systematically evaluate 
the methodological quality of the quantitative study 
designs. The findings will be analysed and a table of 
evidences will be constructed to grade the recommen-
dations based on American Society of Plastic Surgeons’ 
(ASPS) Evidence Rating Scale for Therapeutic Studies 
24scale for grading recommendations.
Meta-analytic approach
The meta- analysis will be conducted using the Compre-
hensive Meta- Analysis (CMA V.3, Biostat, Englewood, 
USA). The synthesised effect size will be reported as the 
standard difference in mean with 95% CI. The standard 
mean difference indicates the difference between the 
means of two groups divided by their pooled SD. The 
data for the meta- analysis will be entered as continuous 
outcomes under the random effects model to account 
for variations between study methodologies. Heteroge-
neity will be assessed using the Q- value statistic and the 
I2 statistic to indicate heterogeneity as a percentage. A 
p value <0.05 will be considered statistically significant 
for all analyses.
dISCuSSIOn
The main aim of this study is to systematically review 
the behavioural central auditory function assessments 
that have been used in studies with participants diag-
nosed with AD or in its preclinical stages. The results of 
the review will provide information about behavioural 
central auditory measures that are sensitive to the 
changes in auditory function in older adults with AD 
and its preclinical stages. This will help to design clin-
ical trials to examine the potential impact of hearing 
and communication rehabilitation for individuals at 
risk of AD. We postulate that this review will be useful 
to a variety of stakeholders who have an interest in the 
care of AD and related disorders.
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